Los anlogos de GLP-1 son medicamentos que imitan una hormona intestinal natural que se libera despus de comer y que participa en el control del apetito y la glucosa
Month 3 : If youre tolerating dose increases well, this is when more meaningful trends appear
A thoughtful clinician might argue against switching in one specific scenario: patients with a strong family history of medullary thyroid carcinoma or MEN2 syndrome
This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications
Effects of Semaglutide on Stroke subtypes in type 2 diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6